Abstract
A fatal case of Neuroleptic Malignant Syndrome (NMS) affecting a middle-aged woman is presented. Most of the signs and symptoms described for NMS were present and death occurred three hours after the onset of hyperpyrexia. Laboratory and postmortem findings were non-specific. The uses and risks of Haloperidol and Phenelzine on a patient with severe liver impairment are considered. Finally, the medico-legal implications in the context of sudden unexpected death are mentioned.
Get full access to this article
View all access options for this article.
References
1.
Abbott
R. J.
Loizou
L.
(1986 ) Neuroleptic Malignant syndrome . Br. J. Psychiat.
148 , 47 –51 .
2.
Anonymous
(1984 ) Neuroleptic Malignant Syndrome (editorial) Lancet
1 , 545 .
3.
Cope
R. V.
Gregg
E. M.
(1983 ) Neuroleptic Malignant Syndrome . BMJ.
286 , 1 , 1938 .
4.
Clough
C. G.
(1983 ) Neuroleptic Malignant Syndrome. BMJ
287 , 2 , 128 –9 .
5.Drugs, Facts and Comparisons (1990 ) Facts and Comparisons Inc. J. B. Lippincott Co., Philadelphia, USA, 1156.
6.
Fogel
B. S.
Goldberg
R. J.
(1985 ) Neuroleptic Malignant Syndrome . N. Eng. J. Med.
313 , 20 , 163.
7.
Guze
B.
Hand Bazter
L. R.
(1985 ) Neuroleptic Malignant Syndrome
N. Engl. J. Med.
313 , 3 , 163.
8.
Horn
E.
Boleslaw
L.
La Pierre
I.
Hrdina
P.
(1983 ) Hypothalamicpathology in the Neuroleptic Malignant Syndrome . Am. J. Psychiat.
145 , 5 , 617 –20 .
9.
Jones
E. H.
Dawson
A.
(1989 ) Neuroleptic Malignant Syndrome: A case report with postmortem brain and musclepathology . J. Neurol-Neurosurg Psychiat.
52 , 8 , 1006 –9 .
10.
Keck
P. E.
Pope
H. G.
McElroy
S. L.
(1987 ) Frequency and presentation of Neuroleptic Malignant Syndrome: A prospective study . Am. J. Psychiat.
144 , 10 , 1344 –6 .
11.
Kish
S. J.
Kleinert
R.
Minauf
M.
Gilbert
J.
Walter
G. F.
Slimovitch
C.
Maurer
E.
Rezvani
Y.
Meyers
R.
Horny Kiewicz
O.
(1990 ) Brain neurotransmitter changes in three patients who had a fatal Hyperthermia Syndrome . Am. J. Psychiat.
147 , 10 , 1358 –63 .
12.
Levenson
J. L.
(1985 ) Neuroleptic Malignant Syndrome . Am. J. Psychiat.
142 , 10 , 1137 –45 .
13.
Linden
H. C.
Rumack
B. H.
Strehkle
C.
Prairie
G.
(1984 ) Monoamine oxidase inhibitor overdose. Ann. Emerg. Med.
13 , 1137 –44 .
14.
Martin
D. T.
Swash
M.
(1987 ) Muscle pathology in the neuroleptic malignant syndrome . J. Neurol.
235 , 120 –21 .
15.
Schibuck
M.
Schachter
D.
(1986 ) A role for cathecolamines in the pathogenesis of neuroleptic malignant syndrome . Can. J. Psychiat.
31 , 66 .
16.
Shalev
A.
Ursano
R. J.
(1988 ) Haloperidol in neuroleptic malignant syndrome . Am. J. Psychiat.
145 (5 ), 653 –4 .
17.
Singh
A. N.
(1983 ) Neuroleptic malignant syndrome . Br. Med. J.
287 , 129 .
18.
Staufenberg
E. F.
Tautam
D.
(1989 ) Malignant hyperpyrexia syndrome in combined treatment . Br. J. Psychiat.
154 (4 ), 577 –8 /
19.
Sternberg
D. E.
(1987 ) Reply to Adityanjee: Neuroleptic Malignant Syndrome, facts and controversies (letter). Am . J. Psychiat.
144 , 8 , 1104 –5
20.
Szabadi
E.
(1984 ) Neuroleptic Malignant Syndrome (editorial). BMJ.
288 , 5 , 1399.
21.
Verrilli
M. R.
Salanga
V. D.
Kozachuck
W. E.
Bennetts
M.
(1987 ) Phenelzine toxicity responsive to Dantrolene . Neurology
37 , 5 , 86 –7 .